Navigation Links
Savient Pharmaceuticals Reports Third Quarter 2009 Financial Results
Date:11/4/2009

al revenues of $2.1 million, compared with a net loss of $60.0 million, or $1.12 per basic and diluted share, on total revenues of $2.1 million for the same period in 2008. The net loss for the nine months ended September 30, 2009 includes a non-cash charge of $24.1 million due to a valuation adjustment relating to warrants that we issued in connection with our April 2009 registered direct offering. On a non-GAAP basis, excluding the $24.1 million non-cash charge, our net loss for the first nine months of 2009 was $66.5 million, or $1.15 per basic and diluted share, compared with a GAAP net loss of $60.0 million for the nine months ended September 30, 2008, or $1.12 per basic and diluted share.

Financial Results of Operations for the Three Months Ended September 30, 2009

Total revenues for the third quarter of 2009 were $0.3 million compared with $0.5 million for the third quarter of 2008, a decrease of $0.2 million mainly due to lower gross sales of Oxandrin® as a result of decreased overall demand for the product from increased generic competition. Additionally, we adjusted our Oxandrin product return reserve in both the current and prior year quarters to reflect higher actual return experience. We expect that sales of Oxandrin will continue to decline slightly or remain flat in future periods. The decrease in Oxandrin sales was partially offset by a $0.1 million increase in sales of our authorized generic oxandrolone, due to increased market share being achieved by Watson Pharmaceuticals, Inc. (Watson), our authorized generic distributor.

Research and development expenses for the third quarter of 2009 were $17.7 million, compared with $10.9 million for the third quarter of 2008, an increase of $6.8 million, or 62%. The increase is primarily due to $4.5 million in contingency charges recorded in the third quarter of 2009 relating to amending the fee schedule and total obligation under our services agreement with
'/>"/>

SOURCE Savient Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. Savient Announces FDAs Advisory Panel to Review Pegloticase for Treatment-Failure Gout Patients
2. Savient Provides Update on Pegloticase BLA
3. Savient Pharmaceuticals Announces Proposed Public Offering of Common Stock
4. Savient Pharmaceuticals Prices Underwritten Offering of Common Stock
5. Savient Pharmaceuticals Announces Closing of Public Offering and Exercise of Over-Allotment Option
6. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
7. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
8. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
9. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
10. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
11. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... West Pharmaceutical Services, Inc. (NYSE: WST ) ... payment of the first-quarter 2010 cash dividend of $0.16 ... 3, 2010 to shareholders of record on January 20, ... is a global manufacturer of components and systems for ... and closures and disposable components used in syringe, IV ...
(Date:12/15/2009)... -- SRI International, an independent nonprofit research and ... patent 7,592,021 for a new bioadhesive drug delivery ... the human body,s mucous membranes. This needle-free option ... a much longer release time compared to alternatives ... is an effective means to introduce drugs across ...
(Date:12/15/2009)... Flextronics (Nasdaq: FLEX ) ... previously announced acquisition of SloMedical S.R.O., a ... ranging from tubing sets to complex devices ... Flextronics provides a broad set of capabilities ... customers. Terms of the deal were not ...
Breaking Medicine Technology:SRI International Receives U.S. Patent for Needle-Free Transmucosal Drug Delivery System 2SRI International Receives U.S. Patent for Needle-Free Transmucosal Drug Delivery System 3SRI International Receives U.S. Patent for Needle-Free Transmucosal Drug Delivery System 4SRI International Receives U.S. Patent for Needle-Free Transmucosal Drug Delivery System 5Flextronics Completes SloMedical Acquisition 2NOVAVAX Completes First Stage of Enrollment in Pivotal H1N1 Influenza Vaccine Study in the Country of Mexico 14845 1NOVAVAX Completes First Stage of Enrollment in Pivotal H1N1 Influenza Vaccine Study in the Country of Mexico 14845 2NOVAVAX Completes First Stage of Enrollment in Pivotal H1N1 Influenza Vaccine Study in the Country of Mexico 14845 3Triage Wireless Inc Becomes Sotera Wireless Inc 6282 1nContact Announces Initiation of Clinical Trials for the Treatment of Atrial Fibrillation in Open Chest Procedures 6278 1nContact Announces Initiation of Clinical Trials for the Treatment of Atrial Fibrillation in Open Chest Procedures 6278 2
... 27, 2007 - Columbia,Laboratories, Inc. (NASDAQ: CBRX) ... pharmacokinetic study of,vaginally-administered lidocaine, which the Company ... 42-subject study was designed to provide data ... vaginal lidocaine,formulation at three dose strengths over ...
... of ONCONASE for,Treatment of Neuroblastoma, BLOOMFIELD, N.J., ... announced that new data show ONCONASE,the company's ... and,chemoresistant neuroblastoma cells. , The pre-clinical in ... Cancer,Letters (2007; Vol. 250, Issue 1: 107-116) ...
Other Medicine Technology:Columbia Laboratories Reports Positive Results from Multi-dose,Pharmacokinetic Study of Vaginally-administered Lidocaine 2Columbia Laboratories Reports Positive Results from Multi-dose,Pharmacokinetic Study of Vaginally-administered Lidocaine 3In Vitro and In Vivo Data Show Alfacell's Onocanse is Active,Against Naive and Chemoresistant Neuroblastoma Cells 2In Vitro and In Vivo Data Show Alfacell's Onocanse is Active,Against Naive and Chemoresistant Neuroblastoma Cells 3
(Date:12/15/2009)... -- The new compact LifeSpan TR200 folding treadmill, made ... ), was highly praised by treadmill review groups in ... compact TR200 folding treadmill received awards for Best New ... ,, The compact LifeSpan TR200 treadmill is designed ... "This category buster is a very compact treadmill that ...
(Date:12/15/2009)... of 30 Individuals Charged in Miami, Detroit and ... Billing to Medicare ,, WASHINGTON, Dec. ... in three cities for their alleged roles in ... false Medicare claims as part of the continuing ... of Health and Human Services (HHS) Secretary Kathleen ...
(Date:12/15/2009)... chronic obstructive pulmonary disease, or COPD, with increased activity ... body,s immune system. , The University of Michigan ... the immune system,s role in COPD, a serious, progressive ... with wheezing, shortness of breath, chest tightening and other ... to find better ways to detect and treat the ...
(Date:12/15/2009)... decade, the United Nations Foundation has led the fight ... World Malaria Report 2009 that the global strategies for ending malaria ... Health for the United Nations Foundation , ... Washington, ... United Nations Foundation has led the fight against malaria, ...
(Date:12/15/2009)... changes increases risk in teens, study suggests , , TUESDAY, ... or obese increases the risk of obstructive sleep apnea, ... for younger children, Australian researchers have found. , In ... to 18, who were referred for evaluation of snoring ... among those aged 12 and older the risk of ...
Breaking Medicine News(10 mins):Health News:Treadmill Reviews Rate Compact LifeSpan Treadmill Best Treadmill 2Health News:Medicare Fraud Strike Force Expands Operations Into Brooklyn, N.Y.; Tampa, Fla.; and Baton Rouge, La. 2Health News:Medicare Fraud Strike Force Expands Operations Into Brooklyn, N.Y.; Tampa, Fla.; and Baton Rouge, La. 3Health News:Medicare Fraud Strike Force Expands Operations Into Brooklyn, N.Y.; Tampa, Fla.; and Baton Rouge, La. 4Health News:Medicare Fraud Strike Force Expands Operations Into Brooklyn, N.Y.; Tampa, Fla.; and Baton Rouge, La. 5Health News:Immune cell activity linked to worsening COPD 2Health News:Immune cell activity linked to worsening COPD 3Health News:Statement by Dr. Daniel Carucci, Vice President for Global Health for the United Nations Foundation, on Progress Shown in World Malaria Report 2009 2Health News:Puberty May Trigger Sleep Apnea in Overweight Kids 2
... Therapy Association (APTA) has said that "Blackberry Thumb" should ... is a repetitive-stress injury that// occurs due to the ... ,"The use of PDAs (personal digital assistants) is no ... workplace," said Margot Miller, president of the APTA's Occupational ...
... Lionel Richie was so fearful over his daughter Nicole's drastic weight ... and find out the problem.// ,According to contactmusic.com, Richie ... she had an eating disorder. ,He says: "Believe ... you know, I went to her, and I said, 'Okay, what ...
... Babies are exposed to certain harmful chemicals before they are ... the need for pregnant women to be careful about their ... at the University of Granada, Spain, tested blood samples taken ... 15 different types of pesticide, reported the online edition of ...
... of Kansas Hospital have a new tool in the ... that has been helping doctors// in other areas improve ... the past several months Dr. William Smith and Dr. ... imaging center, have been working with new software for ...
... say that there is nothing that matches gambling. Not even ... addict//. ,There has been an upsurge of gambling ... with gambling problems. According to some experts, this has led ... ,"It's related to other addictions, like alcoholism and tobacco addiction. ...
... doctors specializing in sports medicine today to meet the level ... hosted by UK. ,Presently physicians are calling on primary ... of treat sports injuries as well as to help tackle ... Royal College of Physicians specialists are the key to improving ...
Other Medicine News:Health News:Babies in Womb Exposed to Harmful Chemicals 2Health News:Compulsive Gambling – a psychiatric disorde 2Health News:Sports Doctors too few for 2012 Olympics 2
... SOF'WIRE Cable System provides immediate, stable, ... to conventional monofilament wire, SOF'WIRE is ... with ease and reproducibility. Stainless Steel ... optimal strength, durability and conformity. ...
... Minimally Invasive Hip Instruments are ... through a mini-incision using a ... of instruments helps reduce the ... THA by optimizing exposure and ...
The Endotrac™ System includes an Obturator, Slotted Cannula, Synovial Elevator, Ligament Probe, Ligament Rasp, Blade Handle, two Retractors and sterilizable tray. The Endotrac&trade....
Instrument set for carpal tunnel release....
Medicine Products: